| Ident. | Authors (with country if any) | Title |
|---|
| 000079 (2015) |
Stanley Fahn [États-Unis] | Reply: Oleh Hornykiewicz's contribution to the l-dopa story. |
| 000109 (2015) |
Eugene V. Mosharov [États-Unis] ; Anders Borgkvist ; David Sulzer | Presynaptic effects of levodopa and their possible role in dyskinesia. |
| 000139 (2015) |
Werner Poewe [Autriche] ; Angelo Antonini | Novel formulations and modes of delivery of levodopa. |
| 000190 (2015) |
T Celeste Napier [États-Unis] ; Jean-Christophe Corvol ; Anthony A. Grace ; Jamie D. Roitman ; James Rowe ; Valerie Voon ; Antonio P. Strafella | Linking neuroscience with modern concepts of impulse control disorders in Parkinson's disease. |
| 000192 (2015) |
C Warren Olanow [États-Unis] | Levodopa: effect on cell death and the natural history of Parkinson's disease. |
| 000193 (2015) |
Stanley Fahn [États-Unis] ; Werner Poewe [Autriche] | Levodopa: 50 years of a revolutionary drug for Parkinson disease. |
| 000195 (2015) |
Peter A. Lewitt [États-Unis] | Levodopa therapy for Parkinson's disease: Pharmacokinetics and pharmacodynamics. |
| 000213 (2015) |
Oscar S. Gershanik [Argentine] | Improving L-dopa therapy: the development of enzyme inhibitors. |
| 000237 (2015) |
Andrew J. Lees [Royaume-Uni] ; Eduardo Tolosa ; C Warren Olanow | Four pioneers of L-dopa treatment: Arvid Carlsson, Oleh Hornykiewicz, George Cotzias, and Melvin Yahr. |
| 000250 (2015) |
Ji Hyun Ko [États-Unis] ; Renata P. Lerner ; David Eidelberg | Effects of levodopa on regional cerebral metabolism and blood flow. |
| 000294 (2015) |
Camila Catherine Aquino [Canada] ; Susan H. Fox | Clinical spectrum of levodopa-induced complications. |
| 000295 (2015) |
Daniel Weintraub [États-Unis] ; Anthony S. David ; Andrew H. Evans ; Jon E. Grant ; Mark Stacy | Clinical spectrum of impulse control disorders in Parkinson's disease. |
| 000309 (2015) |
Isabelle Beaulieu-Boire [Canada] ; Anthony E. Lang | Behavioral effects of levodopa. |
| 000355 (2015) |
Oleh Hornykiewicz [Autriche] | 50 years of levodopa. |
| 000371 (2014) |
Rupam Borgohain [Inde] ; Jozsef Szasz ; Paolo Stanzione ; Chandrashekhar Meshram ; Mohit H. Bhatt ; Dana Chirilineau ; Fabrizio Stocchi ; Valentina Lucini ; Rodolfo Giuliani ; Emma Forrest ; Patricia Rice ; Ravi Anand | Two-year, randomized, controlled study of safinamide as add-on to levodopa in mid to late Parkinson's disease. |
| 000404 (2014) |
Andrew B. West | Ten Years and Counting: Moving Leucine-Rich Repeat Kinase 2 Inhibitors to the Clinic |
| 000407 (2014) |
Barbara Picconi [Italie] ; Paolo Calabresi | Targeting metabotropic glutamate receptors as a new strategy against levodopa-induced dyskinesia in Parkinson's disease? |
| 000453 (2014) |
Robert A. Hauser [États-Unis] ; Dee Silver ; Azhar Choudhry ; Eli Eyal ; Stuart Isaacson | Randomized, controlled trial of rasagiline as an add-on to dopamine agonists in Parkinson's disease. |
| 000473 (2014) |
Mathieu Favier [France] ; Theo Duran ; Carole Carcenac ; Guillaume Drui ; Marc Savasta ; Sebastien Carnicella | Pramipexole reverses Parkinson's disease-related motivational deficits in rats. |
| 000496 (2014) |
Alberto J. Espay [États-Unis] ; Peter A. Lewitt ; Horacio Kaufmann | Norepinephrine deficiency in Parkinson's disease: the case for noradrenergic enhancement. |
| 000558 (2014) |
Elisabeth B. Lucassen [États-Unis] ; Nicholas W. Sterling [États-Unis] ; Eun-Young Lee [États-Unis] ; Honglei Chen [États-Unis] ; Mechelle M. Lewis [États-Unis] ; Lan Kong [États-Unis] ; Xuemei Huang [États-Unis] | History of smoking and olfaction in Parkinson’s disease |
| 000562 (2014) |
Gordon W. Duncan [Royaume-Uni] ; Tien K. Khoo ; Alison J. Yarnall ; John T. O'Brien ; Shirley Y. Coleman ; David J. Brooks ; Roger A. Barker ; David J. Burn | Health-related quality of life in early Parkinson's disease: the impact of nonmotor symptoms. |
| 000570 (2014) |
Pantelis Stathis [Grèce] ; Vasilios Tzias ; Pavlos Argyris ; Georgia Barla ; Maria Maltezou | Gastric bezoar complication of Duodopa(®) therapy in Parkinson's disease, treated with Coca-Cola(®). |
| 000598 (2014) |
Peter A. Lewitt [États-Unis] ; F Jacob Huff ; Robert A. Hauser ; Dan Chen ; Dmitri Lissin ; Katie Zomorodi ; Kenneth C. Cundy | Double-blind study of the actively transported levodopa prodrug XP21279 in Parkinson's disease. |
| 000599 (2014) |
Alice Laudisio [Italie] ; Davide L. Vetrano ; Eleonora Meloni ; Diego Ricciardi ; Francesco Franceschi ; Anna Rita Bentivoglio ; Roberto Bernabei ; Giuseppe Zuccalà | Dopaminergic agents and nutritional status in Parkinson's disease. |
| 000653 (2014) |
Christian R. Baumann [Suisse] ; Ulrike Held ; Philipp O. Valko ; Miriam Wienecke ; Daniel Waldvogel | Body side and predominant motor features at the onset of Parkinson's disease are linked to motor and nonmotor progression. |
| 000658 (2014) |
Shraddha Sapkota [Canada] ; Myrlene Gee ; Jennifer Sabino ; Derek Emery ; Richard Camicioli | Association of homocysteine with ventricular dilatation and brain atrophy in Parkinson's disease. |
| 000699 (2013) |
Christopher G. Goetz [États-Unis] ; Glenn T. Stebbins ; Kathryn A. Chung ; Robert A. Hauser ; Janis M. Miyasaki ; Anthony P. Nicholas ; Werner Poewe [Autriche] ; Klaus Seppi ; Olivier Rascol ; Mark A. Stacy ; John G. Nutt ; Caroline M. Tanner ; Alison Urkowitz ; Jean A. Jaglin ; Song Ge | Which dyskinesia scale best detects treatment response? |
| 000714 (2013) |
Anthony E. Lang [Canada] ; Eldad Melamed ; Werner Poewe [Autriche] ; Olivier Rascol | Trial designs used to study neuroprotective therapy in Parkinson's disease. |
| 000719 (2013) |
Yoshikuni Mizuno [Japon] ; Masahiro Nomoto ; Tomoyoshi Kondo ; Kazuko Hasegawa ; Miho Murata ; Masahiro Takeuchi ; Junji Ikeda ; Takayuki Tomida ; Nobutaka Hattori | Transdermal rotigotine in early stage Parkinson's disease: a randomized, double-blind, placebo-controlled trial. |
| 000742 (2013) |
Jau-Shin Lou [États-Unis] ; Diana M. Dimitrova [États-Unis] ; Richard Hammerschlag [États-Unis] ; John Nutt [États-Unis] ; Elizabeth A. Hunt [États-Unis] ; Ryan W. Eaton [États-Unis] ; Sarah C. Johnson [États-Unis] ; Melanie D. Davis [États-Unis] ; Grace C. Arnold [États-Unis] ; Sarah B. Andrea [États-Unis] ; Barry S. Oken [États-Unis] | The effect of expectancy and personality on cortical excitability in Parkinson’s disease |
| 000767 (2013) |
Erwan Bezard [France] ; Elisabetta Tronci ; Elsa Y. Pioli ; Qin Li ; Gregory Porras ; Anders Björklund ; Manolo Carta | Study of the antidyskinetic effect of eltoprazine in animal models of levodopa-induced dyskinesia. |
| 000788 (2013) |
Amit Batla [Royaume-Uni] ; Maria Stamelou [Royaume-Uni] ; Niccolo Mencacci [Royaume-Uni, Italie] ; Anthony H. Schapira [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] | Ropinirole monotherapy induced severe reversible dyskinesias in Parkinson’s disease |
| 000789 (2013) |
Katherine L. Possin ; Gail A. Kang ; Christine Guo ; Eric M. Fine ; Andrew J. Trujillo ; Caroline A. Racine ; Reva Wilheim ; Erica T. Johnson ; Jennifer L. Witt ; William W. Seeley ; Bruce L. Miller ; Joel H. Kramer | Rivastigmine is Associated with Restoration of Left Frontal Brain Activity in Parkinson’s Disease |
| 000810 (2013) |
Onanong Jitkritsadakul ; Priya Jagota ; Sitthi Petchrutchatachart ; Lalana Sansopha ; Rungsun Rerknimitr ; Roongroj Bhidayasiri | Recurrent pancreatitis as a rare complication of duodenal levodopa infusion treatment. |
| 000814 (2013) |
Rupam Borgohain [Inde] ; J. Szasz [Roumanie] ; P. Stanzione [Italie] ; C. Meshram [Inde] ; M. Bhatt [Inde] ; D. Chirilineau [Roumanie] ; F. Stocchi [Italie] ; V. Lucini [Italie] ; R. Giuliani [Italie] ; E. Forrest [Italie] ; P. Rice [États-Unis] ; R. Anand [Suisse] | Randomized trial of safinamide add-on to levodopa in Parkinson's disease with motor fluctuations |
| 000821 (2013) |
Jesse Bastiaens [États-Unis] ; Benjamin J. Dorfman [États-Unis] ; Paul J. Christos [États-Unis] ; Melissa J. Nirenberg [États-Unis] | Prospective Cohort Study of Impulse Control Disorders in Parkinson’s Disease |
| 000839 (2013) |
Asako Yoritaka [Japon] ; Masashi Takanashi ; Masaaki Hirayama ; Toshiki Nakahara ; Shigeo Ohta ; Nobutaka Hattori | Pilot study of H₂ therapy in Parkinson's disease: a randomized double-blind placebo-controlled trial. |
| 000844 (2013) |
| Phase II safety, tolerability, and dose selection study of isradipine as a potential disease-modifying intervention in early Parkinson's disease (STEADY-PD). |
| 000847 (2013) |
E. D. Anderson ; F. B. Horak ; M. R. Lasarev ; J. G. Nutt | Performance of a motor task learned ON levodopa deteriorates when subsequently practiced OFF |
| 000855 (2013) |
Madeleine E. Sharp [États-Unis] ; Karen S. Marder [États-Unis] ; Lucien Côté [États-Unis] ; Lorraine N. Clark [États-Unis] ; William C. Nichols ; Jean-Paul Vonsattel [États-Unis] ; Roy N. Alcalay [États-Unis] | Parkinson’s disease with Lewy bodies associated with a heterozygous PARKIN dosage mutation |
| 000861 (2013) |
Alex A. Macdonald [Canada] ; Oury Monchi ; Ken N. Seergobin ; Hooman Ganjavi ; Ruzbeh Tamjeedi ; Penny A. Macdonald | Parkinson's disease duration determines effect of dopaminergic therapy on ventral striatum function. |
| 000876 (2013) |
Lorraine V. Kalia [Canada] ; Jonathan M. Brotchie ; Susan H. Fox | Novel nondopaminergic targets for motor features of Parkinson's disease: review of recent trials. |
| 000890 (2013) |
Roberto Ceravolo [Italie] ; Giovanni Cossu ; Monica Bandettini Di Poggio ; Lucio Santoro ; Paolo Barone ; Maurizio Zibetti ; Daniela Frosini ; Valentina Nicoletti ; Fiore Manganelli ; Rosa Iodice ; Marina Picillo ; Aristide Merola ; Leonardo Lopiano ; Alessandra Paribello ; Davide Manca ; Maurizio Melis ; Roberta Marchese ; Paolo Borelli ; Alessandra Mereu ; Paolo Contu ; Giovanni Abbruzzese ; Ubaldo Bonuccelli | Neuropathy and levodopa in Parkinson's disease: evidence from a multicenter study. |
| 000897 (2013) |
Daniel J. Burdick [États-Unis] ; Alida Griffith ; Pinky Agarwal | Mydriasis in a Parkinson disease patient on low-dose carbidopa/levodopa. |
| 000922 (2013) |
Radu Constantinescu [États-Unis] ; Jordan Elm [États-Unis] ; Peggy Auinger [États-Unis] ; Saloni Sharma [États-Unis] ; Erika F. Augustine [États-Unis] ; Laith Khadim [États-Unis] ; Karl Kieburtz [États-Unis] | Malignant Melanoma in Early-Treated Parkinson's Disease: The NET-PD Trial |
| 000928 (2013) |
Ganesvaran Ganga [Australie] ; Jane E. Alty ; Benjamin G. Clissold ; Craig D. Mccoll ; Katrina A. Reardon ; Mark Schiff ; Peter A. Kempster | Longitudinal study of levodopa in Parkinson's disease: effects of the advanced disease phase. |
| 000929 (2013) |
Stewart A. Factor [États-Unis] ; Kenneth Wolski ; Daniel M. Togasaki ; Susan Huyck ; Marc Cantillon ; T W Ho ; Robert A. Hauser ; Emmanuelle Pourcher | Long-term safety and efficacy of preladenant in subjects with fluctuating Parkinson's disease. |
| 000936 (2013) |
María José Catalán [Espagne] ; Eduardo De Pablo-Fernández ; Clara Villanueva ; Servando Fernández-Diez ; Teresa Lape A-Montero ; Rocío García-Ramos ; Eva L Pez-Valdés | Levodopa infusion improves impulsivity and dopamine dysregulation syndrome in Parkinson's disease. |
| 000937 (2013) |
Maria Papathanou [Pays-Bas] ; Rika Van Der Laan ; Peter Jenner ; Sarah Rose ; Andrew C. Mccreary | Levodopa infusion does not decrease the onset of abnormal involuntary movements in parkinsonian rats. |
| 000939 (2013) |
Alexandre Krainik [France] ; Audrey Maillet ; Vanessa Fleury ; Mehmet Sahin ; Irène Troprès ; Laurent Lamalle ; Stephane Thobois ; Valerie Fraix ; Marjorie Villien ; Jan Warnking ; Pierre Pollak ; Serge Pinto ; Paul Krack | Levodopa does not change cerebral vasoreactivity in Parkinson's disease. |
